Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 1/2 2Phase 1 2

Status

Recruiting 3Active not recruiting 2Unknown 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Carcinoma, Non-Small-Cell Lung 17Carcinoma, Hepatocellular 8Nasopharyngeal Carcinoma 7Recurrence 6Neoplasms 6Esophageal Neoplasms 6Breast Neoplasms 6Stomach Neoplasms 5Neoplasm Metastasis 5Esophageal Squamous Cell Carcinoma 5Colorectal Neoplasms 5Locally Advanced Rectal Cancer 4Carcinoma, Renal Cell 4Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma 3Rectal Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Leukemia, Myeloid, Acute 2Hyperthermia 2Chondrosarcoma 2Carcinoma, Transitional Cell 2

Interventions

Cisplatin 88Fluorouracil 71Paclitaxel 69Radiotherapy 63Oxaliplatin 55Irinotecan 37Docetaxel 36Carboplatin 36Leucovorin 34Capecitabine 28Radiation 25Surgical Procedures, Operative 22Drug Therapy 19pembrolizumab 18Cetuximab 15Bevacizumab 15Nivolumab 14tislelizumab 12camrelizumab 11Neoadjuvant Therapy 11Esophagectomy 11Chemoradiotherapy 11S 1 (combination) 10Albumin-Bound Paclitaxel 10nimotuzumab 9Trastuzumab 9durvalumab 8Radiotherapy, Intensity-Modulated 8Gefitinib 7Epirubicin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Esophageal Neoplasms × Immune Checkpoint Inhibitors × Clear all
NCT07519486 2026-04-15

INS-ESCC-CT

Sichuan University

Phase 2 Recruiting
118 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05621707 2026-02-02

RICE

Shanghai Chest Hospital

Phase 2 Active not recruiting
50 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT05491616 2025-02-13

SANO-3

Erasmus Medical Center

Phase 2 Active not recruiting
77 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06084897 2024-06-14

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
120 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06186609 2024-01-02

PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

Affiliated Hospital of Nantong University

Phase 2 Recruiting
68 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05007145 2021-12-21

REVO

Fujian Cancer Hospital

Phase 2 Unknown
92 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡